Drug
Carmustine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Myelodysplastic Syndrome | 296 | 94.9 | 101.4 | signal |
| 2 | Acute Myeloid Leukaemia | 172 | 50.8 | 52.7 | signal |
| 3 | Brain Oedema | 137 | 49.9 | 51.4 | signal |
| 4 | Mucosal Inflammation | 219 | 38.5 | 40.4 | signal |
| 5 | Haematotoxicity | 65 | 32.1 | 32.5 | signal |
| 6 | Febrile Neutropenia | 391 | 27.0 | 29.4 | signal |
| 7 | Pneumocystis Jirovecii Pneumonia | 50 | 22.9 | 23.1 | signal |
| 8 | Therapy Partial Responder | 69 | 20.9 | 21.2 | signal |
| 9 | Cytomegalovirus Infection | 74 | 20.3 | 20.6 | signal |
| 10 | Cytopenia | 50 | 19.1 | 19.3 | signal |
| 11 | Acute Respiratory Distress Syndrome | 63 | 16.2 | 16.5 | signal |
| 12 | Bacteraemia | 40 | 15.5 | 15.6 | signal |
| 13 | Basal Cell Carcinoma | 50 | 14.6 | 14.7 | signal |
| 14 | Cytokine Release Syndrome | 60 | 14.4 | 14.5 | signal |
| 15 | Lymphoma | 47 | 13.8 | 14.0 | signal |
| 16 | Clostridium Difficile Colitis | 28 | 12.0 | 12.1 | signal |
| 17 | Lymphopenia | 37 | 12.0 | 12.1 | signal |
| 18 | Disease Progression | 292 | 11.3 | 12.0 | signal |
| 19 | Nephropathy Toxic | 27 | 11.0 | 11.1 | signal |
| 20 | Septic Shock | 101 | 10.6 | 10.9 | signal |
| 21 | Thrombocytopenia | 250 | 10.2 | 10.7 | signal |
| 22 | Status Epilepticus | 23 | 9.3 | 9.3 | signal |
| 23 | Post Procedural Complication | 39 | 9.2 | 9.3 | signal |
| 24 | Blood Lactate Dehydrogenase Increased | 32 | 9.1 | 9.2 | signal |
| 25 | Bone Marrow Failure | 41 | 9.1 | 9.2 | signal |
| 26 | Staphylococcal Infection | 66 | 9.1 | 9.2 | signal |
| 27 | Intestinal Perforation | 22 | 8.9 | 9.0 | signal |
| 28 | Candida Infection | 32 | 8.7 | 8.8 | signal |
| 29 | Pancytopenia | 105 | 8.6 | 8.8 | signal |
| 30 | Ataxia | 22 | 8.4 | 8.4 | signal |
| 31 | Wound Infection | 20 | 8.4 | 8.4 | signal |
| 32 | Colitis | 69 | 8.3 | 8.5 | signal |
| 33 | Multi-organ Failure | 32 | 8.3 | 8.4 | signal |
| 34 | Glomerular Filtration Rate Decreased | 22 | 8.3 | 8.3 | signal |
| 35 | Device Related Infection | 28 | 8.3 | 8.3 | signal |
| 36 | Drug Toxicity | 25 | 8.2 | 8.3 | signal |
| 37 | Pneumonitis | 48 | 8.1 | 8.2 | signal |
| 38 | Hepatotoxicity | 39 | 8.0 | 8.1 | signal |
| 39 | Leukopenia | 84 | 7.7 | 7.8 | signal |
| 40 | Posterior Reversible Encephalopathy Syndrome | 16 | 7.7 | 7.7 | signal |
| 41 | Multiple Organ Dysfunction Syndrome | 46 | 7.5 | 7.6 | signal |
| 42 | Myelosuppression | 56 | 7.5 | 7.6 | signal |
| 43 | Lymphadenopathy | 58 | 7.5 | 7.5 | signal |
| 44 | Hepatocellular Injury | 23 | 7.4 | 7.4 | signal |
| 45 | Neurotoxicity | 27 | 7.1 | 7.1 | signal |
| 46 | Neutropenia | 206 | 6.9 | 7.2 | signal |
| 47 | Hemiparesis | 25 | 6.7 | 6.7 | signal |
| 48 | Cholestasis | 28 | 6.7 | 6.7 | signal |
| 49 | Bacterial Infection | 27 | 6.6 | 6.7 | signal |
| 50 | Thrombotic Microangiopathy | 14 | 6.6 | 6.6 | signal |
| 51 | Sepsis | 159 | 6.5 | 6.7 | signal |
| 52 | Cerebral Infarction | 34 | 6.3 | 6.4 | signal |
| 53 | Ileus | 17 | 6.3 | 6.3 | signal |
| 54 | Subarachnoid Haemorrhage | 14 | 6.2 | 6.3 | signal |
| 55 | Neoplasm Progression | 48 | 6.2 | 6.3 | signal |
| 56 | Disease Recurrence | 65 | 6.2 | 6.3 | signal |
| 57 | Agranulocytosis | 24 | 5.9 | 5.9 | signal |
| 58 | Malignant Neoplasm Progression | 129 | 5.8 | 5.9 | signal |
| 59 | Infection | 177 | 5.6 | 5.8 | signal |
| 60 | Stomatitis | 73 | 5.5 | 5.5 | signal |
| 61 | Respiratory Failure | 86 | 5.4 | 5.4 | signal |
| 62 | Atelectasis | 11 | 5.2 | 5.2 | signal |
| 63 | Metastases To Lung | 13 | 5.1 | 5.1 | signal |
| 64 | Polyneuropathy | 13 | 5.0 | 5.0 | signal |
| 65 | Convulsion | 63 | 4.9 | 5.0 | signal |
| 66 | Clostridium Difficile Infection | 23 | 4.8 | 4.8 | signal |
| 67 | Subdural Haematoma | 15 | 4.8 | 4.8 | signal |
| 68 | Aphasia | 31 | 4.7 | 4.7 | signal |
| 69 | Tubulointerstitial Nephritis | 19 | 4.6 | 4.6 | signal |
| 70 | Pneumothorax | 16 | 4.6 | 4.6 | signal |
| 71 | Respiratory Tract Infection | 26 | 4.6 | 4.6 | signal |
| 72 | Haemorrhage Intracranial | 15 | 4.5 | 4.6 | signal |
| 73 | Blood Bilirubin Increased | 27 | 4.5 | 4.6 | signal |
| 74 | Acute Respiratory Failure | 19 | 4.5 | 4.5 | signal |
| 75 | Toxic Skin Eruption | 10 | 4.5 | 4.5 | signal |
| 76 | End Stage Renal Disease | 18 | 4.4 | 4.5 | signal |
| 77 | Hyperbilirubinaemia | 10 | 4.4 | 4.4 | signal |
| 78 | Appendicitis | 9 | 4.4 | 4.4 | signal |
| 79 | Fungal Infection | 31 | 4.2 | 4.3 | signal |
| 80 | Drug Eruption | 16 | 4.1 | 4.1 | signal |
| 81 | Paralysis | 13 | 4.1 | 4.1 | signal |
| 82 | Gastric Cancer | 23 | 4.1 | 4.1 | signal |
| 83 | Neutrophil Count Decreased | 36 | 4.0 | 4.1 | signal |
| 84 | Cardiomyopathy | 13 | 4.0 | 4.0 | signal |
| 85 | Osteonecrosis | 29 | 4.0 | 4.0 | signal |
| 86 | Encephalopathy | 21 | 3.9 | 3.9 | signal |
| 87 | Pulmonary Embolism | 81 | 3.9 | 3.9 | signal |
| 88 | Alanine Aminotransferase Increased | 52 | 3.9 | 3.9 | signal |
| 89 | Viral Infection | 28 | 3.8 | 3.8 | signal |
| 90 | Covid-19 Pneumonia | 10 | 3.8 | 3.8 | signal |
| 91 | Autoimmune Disorder | 8 | 3.8 | 3.8 | signal |
| 92 | Nervous System Disorder | 26 | 3.8 | 3.8 | signal |
| 93 | Hepatitis | 21 | 3.7 | 3.7 | signal |
| 94 | Neuropathy Peripheral | 76 | 3.7 | 3.7 | signal |
| 95 | Lymphocyte Count Decreased | 14 | 3.6 | 3.6 | signal |
| 96 | Renal Failure Acute | 34 | 3.6 | 3.6 | signal |
| 97 | Coagulopathy | 13 | 3.6 | 3.6 | signal |
| 98 | Deep Vein Thrombosis | 51 | 3.6 | 3.6 | signal |
| 99 | Ejection Fraction Decreased | 12 | 3.5 | 3.5 | signal |
| 100 | Immune System Disorder | 10 | 3.5 | 3.5 | signal |
| 101 | Scar | 13 | 3.4 | 3.5 | signal |
| 102 | Mental Status Changes | 21 | 3.4 | 3.4 | signal |
| 103 | Intentional Product Use Issue | 66 | 3.4 | 3.4 | signal |
| 104 | Drug Resistance | 19 | 3.4 | 3.4 | signal |
| 105 | Deafness | 19 | 3.3 | 3.3 | signal |
| 106 | Pyrexia | 239 | 3.1 | 3.3 | signal |
| 107 | Drug Level Decreased | 7 | 3.1 | 3.1 | signal |
| 108 | Metastases To Liver | 12 | 3.1 | 3.1 | signal |
| 109 | Pulmonary Fibrosis | 13 | 3.1 | 3.1 | signal |
| 110 | Sudden Death | 7 | 3.0 | 3.0 | signal |
| 111 | Pericardial Effusion | 15 | 3.0 | 3.0 | signal |
| 112 | Dermatitis Allergic | 8 | 2.9 | 2.9 | signal |
| 113 | Oesophagitis | 7 | 2.9 | 2.9 | signal |
| 114 | Product Use In Unapproved Indication | 155 | 2.9 | 3.0 | signal |
| 115 | Pneumonia | 202 | 2.8 | 2.9 | signal |
| 116 | Platelet Count Decreased | 65 | 2.8 | 2.8 | signal |
| 117 | Renal Tubular Necrosis | 6 | 2.8 | 2.8 | signal |
| 118 | Anaemia | 116 | 2.8 | 2.8 | signal |
| 119 | Atrial Fibrillation | 58 | 2.7 | 2.7 | signal |
| 120 | Off Label Use | 515 | 2.7 | 2.9 | signal |
| 121 | Emphysema | 6 | 2.7 | 2.7 | signal |
| 122 | Lung Disorder | 29 | 2.7 | 2.7 | signal |
| 123 | Herpes Zoster | 34 | 2.7 | 2.7 | signal |
| 124 | Eyelid Ptosis | 6 | 2.7 | 2.7 | signal |
| 125 | Inappropriate Antidiuretic Hormone Secretion | 6 | 2.7 | 2.7 | signal |
| 126 | Cerebral Haemorrhage | 21 | 2.7 | 2.7 | signal |
| 127 | Petechiae | 6 | 2.6 | 2.6 | signal |
| 128 | Pleural Effusion | 35 | 2.6 | 2.6 | signal |
| 129 | Jaundice | 15 | 2.5 | 2.5 | signal |
| 130 | Impaired Healing | 18 | 2.5 | 2.5 | signal |
| 131 | Rash Maculo-papular | 12 | 2.5 | 2.5 | signal |
| 132 | Squamous Cell Carcinoma | 5 | 2.4 | 2.4 | no signal |
| 133 | Hepatic Failure | 16 | 2.4 | 2.4 | signal |
| 134 | Renal Impairment | 44 | 2.4 | 2.4 | signal |
| 135 | Coma | 25 | 2.4 | 2.4 | signal |
| 136 | Pulmonary Oedema | 23 | 2.3 | 2.3 | signal |
| 137 | Altered State Of Consciousness | 11 | 2.3 | 2.3 | signal |
| 138 | Ill-defined Disorder | 31 | 2.3 | 2.3 | signal |
| 139 | Respiratory Disorder | 15 | 2.3 | 2.3 | signal |
| 140 | Interstitial Lung Disease | 24 | 2.3 | 2.3 | signal |
| 141 | Thyroid Cancer | 6 | 2.3 | 2.3 | no signal |
| 142 | Epilepsy | 15 | 2.2 | 2.2 | signal |
| 143 | Hepatic Cytolysis | 6 | 2.2 | 2.2 | no signal |
| 144 | Drug Ineffective For Unapproved Indication | 27 | 2.2 | 2.2 | signal |
| 145 | Immunodeficiency | 7 | 2.2 | 2.2 | no signal |
| 146 | Fluid Overload | 7 | 2.2 | 2.2 | no signal |
| 147 | Cardiac Failure | 38 | 2.2 | 2.2 | signal |
| 148 | Hypothyroidism | 15 | 2.1 | 2.1 | signal |
| 149 | Lung Infection | 7 | 2.0 | 2.0 | no signal |
| 150 | Brain Neoplasm | 4 | 2.0 | 2.0 | no signal |
| 151 | Neoplasm | 5 | 2.0 | 2.0 | no signal |
| 152 | Gastric Haemorrhage | 5 | 2.0 | 2.0 | no signal |
| 153 | Splenomegaly | 5 | 1.9 | 1.9 | no signal |
| 154 | Disseminated Intravascular Coagulation | 6 | 1.9 | 1.9 | no signal |
| 155 | Hepatitis C | 5 | 1.9 | 1.9 | no signal |
| 156 | No Therapeutic Response | 5 | 1.8 | 1.8 | no signal |
| 157 | Cyst | 5 | 1.8 | 1.8 | no signal |
| 158 | Tooth Extraction | 5 | 1.8 | 1.8 | no signal |
| 159 | Intestinal Obstruction | 15 | 1.8 | 1.8 | no signal |
| 160 | Drug Reaction With Eosinophilia And Systemic Symptoms | 10 | 1.8 | 1.8 | no signal |
| 161 | Mydriasis | 5 | 1.8 | 1.8 | no signal |
| 162 | Tuberculosis | 5 | 1.8 | 1.8 | no signal |
| 163 | Folliculitis | 4 | 1.8 | 1.8 | no signal |
| 164 | Palmar-plantar Erythrodysaesthesia Syndrome | 9 | 1.7 | 1.8 | no signal |
| 165 | Toxicity To Various Agents | 64 | 1.7 | 1.7 | no signal |
| 166 | Proteinuria | 7 | 1.7 | 1.7 | no signal |
| 167 | Pulmonary Arterial Hypertension | 5 | 1.6 | 1.6 | no signal |
| 168 | Ischaemic Stroke | 6 | 1.5 | 1.5 | no signal |
| 169 | Plasma Cell Myeloma | 13 | 1.5 | 1.5 | no signal |
| 170 | Femur Fracture | 10 | 1.5 | 1.5 | no signal |
| 171 | Diarrhoea Haemorrhagic | 3 | 1.5 | 1.5 | no signal |
| 172 | Leukaemia | 3 | 1.4 | 1.4 | no signal |
| 173 | Metastases To Central Nervous System | 4 | 1.4 | 1.4 | no signal |
| 174 | Anorexia | 4 | 1.4 | 1.4 | no signal |
| 175 | Amenorrhoea | 5 | 1.4 | 1.4 | no signal |
| 176 | Malignant Melanoma | 4 | 1.4 | 1.4 | no signal |
| 177 | Multiple Sclerosis | 14 | 1.3 | 1.3 | no signal |
| 178 | Peritonitis | 6 | 1.3 | 1.3 | no signal |
| 179 | Central Nervous System Lesion | 4 | 1.3 | 1.3 | no signal |
| 180 | Fistula | 3 | 1.2 | 1.2 | no signal |
| 181 | Drug Administration Error | 8 | 1.2 | 1.2 | no signal |
| 182 | Drug Effective For Unapproved Indication | 7 | 1.1 | 1.1 | no signal |
| 183 | Breast Cancer | 13 | 0.6 | 0.6 | no signal |
| 184 | Prostate Cancer | 9 | 0.5 | 0.5 | no signal |
| 185 | Bladder Cancer | 3 | 0.2 | 0.2 | no signal |